23-carboxy-24,25,26,27-tetranorvitamin D3 (calcioic acid) and 24-carboxy-25,26,27-trinorvitamin D3 (cholacalcioic acid):: End products of 25-hydroxyvitamin D3 metabolism in rat kidney through C-24 oxidation pathway

被引:12
作者
Reddy, G. Satyanarayana
Omdahl, John L.
Robinson, Matthew
Wang, Guochun
Palmore, G. Tayhas R.
Vicchio, Domenick
Yergey, Alfred L.
Tserng, Kou-Yi
Uskokovic, Milan R.
机构
[1] Epimer LLC, Providence, RI 02906 USA
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
[3] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA
[4] Brown Univ, Div Engn, Providence, RI 02912 USA
[5] NIH, Bethesda, MD 20892 USA
[6] Case Western Reserve Univ, Dept Nutr & Med, Cleveland, OH 44106 USA
[7] Vet Adm Med Ctr, Cleveland, OH 44106 USA
[8] Bioxell Inc, Nutley, NJ 07110 USA
关键词
25OHD3; 24R; 25(OH)2D3; rat kidney; metabolism; CYP24A1; calcioic acid; cholacalcioic acid; bile acid; vitamin D3;
D O I
10.1016/j.abb.2006.08.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the past two and half decades the elucidation of the metabolic pathways of 250HD(3) and its active metabolite 1 alpha,25(OH)(2)D-3 progressed in parallel. In spite of many advances in this area of vitamin D research, the unequivocal identification of the end products of 250HD(3) metabolism through C-24 oxidation pathway has not been achieved. It is now well established that both 250HD(3) and 1 alpha,25(OH)(2)D-3 are metabolized through the same C-24 oxidation pathway initiated by the enzyme 24-hydroxylase (CYP24A1). Based on the information that the end product of 1 alpha,25(OH)(2)D-3 metabolism through C-24 oxidation pathway is 1 alpha-OH-23- COOH-24,2 5,26,27-tetranor D-3 or calcitroic acid; the metabolism of 250HD(3) into 23-COOH-24,25,26,27-tetranor D-3 has been assumed. Furthermore, a previous study indicated 24-COOH25,26,27-trinor D-3 as a water soluble metabolite of 24R,25(OH)(2)D-3 produced in rat kidney homogenates. Therefore, 24-COOH-25,26,27-trinor D3 was also assumed as another end product of 250HD3 metabolism through C-24 oxidation pathway. We embarked on our present study to provide unequivocal proof for these assumptions. We first studied the metabolism of 250HD(3) at low substrate concentration (3 x 10(-10) M) using [1,2-H-3]250HD(3) as the substrate in the perfused rat kidneys isolated from both normal and vitamin D-3 intoxicated rats. A highly polar water soluble metabolite, labeled as metabolite X was isolated from the kidney perfusate. The amount of metabolite X produced in the kidney of a vitamin D intoxicated rat was about seven times higher than that produced in the kidney of a normal rat. We then produced metabolite X in a quantity sufficient for its structure identification by perfusing kidneys isolated from vitamin D intoxicated rats with high substrate concentration of 250HD(3) (5 x 10(-6) M). Using the techniques of electron impact and thermospray mass spectrometry, we established that the metabolite X contained both 23-COOH-24,25,26,27-tetranor D-3 and 24-COOH-25,26,27-trinor D-3 in a ratio of 4: 1. The same metabolite X containing both acids in the same ratio of 4:1 was also produced when 24R,25(OH)(2)D-3 was used as the starting substrate. Previously, the trivial name of cholacalcioic acid was assigned to 24-COOH-25,26,27-trinorvitamin D-3. Using the same guidelines, we now assign the trivial name of calcioic acid to 23-COOH-24,25,26,27-tetranor D-3. In summary, for the first time our study provides unequivocal evidence to indicate that both calcioic and cholacalcioic acids as the end products of 250HD(3) metabolism in rat kidney through C-24 oxidation pathway. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 30
页数:13
相关论文
共 30 条
  • [1] Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
    Adachi, R
    Honma, Y
    Masuno, H
    Kawana, K
    Shimomura, L
    Yamada, S
    Makishima, M
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (01) : 46 - 57
  • [2] FURTHER OXIDATION OF HYDROXYCALCIDIOL BY CALCIDIOL 24-HYDROXYLASE - A STUDY WITH THE MATURE ENZYME EXPRESSED IN ESCHERICHIA-COLI
    AKIYOSHISHIBATA, M
    SAKAKI, T
    OHYAMA, Y
    NOSHIRO, M
    OKUDA, K
    YABUSAKI, Y
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 335 - 343
  • [3] Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme
    Beckman, MJ
    Tadikonda, P
    Werner, E
    Prahl, J
    Yamada, S
    DeLuca, HF
    [J]. BIOCHEMISTRY, 1996, 35 (25) : 8465 - 8472
  • [4] Bile acids as carcinogens in human gastrointestinal cancers
    Bernstein, H
    Bernstein, C
    Payne, CM
    Dvorakova, K
    Garewal, H
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2005, 589 (01) : 47 - 65
  • [5] BLIGH EG, 1959, CAN J BIOCH PHYSL, V245, pE359
  • [6] DELUCA HF, 1979, VITAMIN D BASIC RES, P445
  • [7] ISOLATION AND CHARACTERIZATION OF 1ALPHA-HYDROXY-23-CARBOXYTETRANORVITAMIN-D - MAJOR METABOLITE OF 1,25-DIHYDROXYVITAMIN-D3
    ESVELT, RP
    SCHNOES, HK
    DELUCA, HF
    [J]. BIOCHEMISTRY, 1979, 18 (18) : 3977 - 3983
  • [8] The epidemiology of vitamin D and colorectal cancer: recent findings
    Giovannucci, E
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (01) : 24 - 29
  • [9] The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)
    Giovannucci, E
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (02) : 83 - 95
  • [10] Horst RL, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P15